CSC Pharmaceuticals Announces the Launch of the Innovative Migraine and Pain Treatment Developed by APR Applied Pharma Research
BALERNA, Switzerland--(BUSINESS WIRE)--Apr 3, 2019--APR Applied Pharma Research's patented formulation of Diclofenac 50 mg powder oral solution for migraine treatment and other pai…
